In form-deprivation myopia (FDM) models, the use of DKK-1, a Wnt/β-catenin pathway antagonist, significantly reduces the expression of Wnt3 and β-catenin, affecting the expression of TGF-β1 and the organization of type I collagen (172). This evidence concerns the gene TGFB1 and myopia.